Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Why Biogen/Eisai's Aducanumab Failure Is Not The End Of Amyloid Hypothesis

Thu, 03/21/2019 - 5:59pm

Biogen and Eisai still have multiple programs testing amyloid-targeting therapies in the treatment of Alzheimer's disease, but pressure for Biogen...

      Related Stories 

Conatus Endures Another NASH Setback With Failure To Hit Fibrosis Endpoint

Thu, 03/21/2019 - 2:08pm

The pan-caspase inhibitor emricasan, partnered with Novartis, misses fibrosis-reduction endpoint in Phase IIb study, following the failure last December of...

      Related Stories 

INFOGRAPHIC: NASH Pipeline: Racing To The Finish

Thu, 03/21/2019 - 11:23am

INFOGRAPHIC: As industry closes in on the first approved drug therapy for non-alcoholic steatohepatitis, our infographic details the dozens of...

      Related Stories 

Scandinavia Serves Up Two Partners For Alexion, In Its Rare Disease Sweet-Spot

Thu, 03/21/2019 - 9:02am

Leading US biotech Alexion is to collaborate with two European biotechs, Affibody and Zealand, on early-stage products for rare diseases...

      Related Stories 

What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers

Thu, 03/21/2019 - 8:46am

With UK biotech venture capital investment at its highest level to date, biotech company building is showing no let up...

      Related Stories 

Merck KGaA Expects Core Franchises, Alliances To Strengthen In China

Wed, 03/20/2019 - 7:33am

Merck KGaA's healthcare business in China will continue to center around its fertility, general medicines and endocrinology therapies while also...

      Related Stories 

Amphera Gears Up To Evaluate Dendritic Cells For Pleural Mesothelioma

Wed, 03/20/2019 - 1:46am

Dutch biotech Amphera has progressed into late-stage clinical studies with dendritic cells activated with an allogeneic lysate of tumor cell...

      Related Stories 

Dong-A Vows Legal Steps As Korea Imposes Heavy Penalties Over Rebates

Tue, 03/19/2019 - 8:50pm

Korea temporarily suspends reimbursement of drugs involved in Dong-A ST’s alleged illegal rebate payments to doctors, raising concerns from the...

      Related Stories 

Urovant’s Vibegron Faces Tough Commercial Climb Despite Phase III Success

Tue, 03/19/2019 - 4:20pm

Roivant subsidiary thinks EMPOWUR data would position the drug as best-in-class in overactive bladder, but investors responded to the data...

      Related Stories 

Price ‘Anchoring’? Zolgensma And The Art Of Managing Gene Therapy Sticker Shock

Tue, 03/19/2019 - 12:54pm

Public statements by Novartis and Avexis suggest Zolgensma could be cost effective at a price up to $5m. Analysts expect...

      Related Stories 

TIME-2b Disappointed: Aerpio’s Lead Product Fails In Diabetic Retinopathy

Tue, 03/19/2019 - 10:01am

As its lead product fails at Phase IIb in diabetic retinopathy, Aerpio’s attentions turn to its other potential indications, but...

      Related Stories 

Abbott Builds Its Digital Reach In India

Tue, 03/19/2019 - 9:38am

Abbott’s new digital initiative in India, which already has 2,000 physicians and 1,000 patients on board, aims to provide services...

      Related Stories